Abstract
The delivery of genetic information to enable the body to produce its own tailored medicine is a promising alternative to recombinant protein therapies. As such, the administration of mRNA offers a potent, flexible and apparently safe platform. Here we discuss the principles and perspectives of mRNA-based therapies focusing on its application in the field of passive immunization in general and for infectious diseases in particular.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
